Nio has been expanding its brand portfolio to help it address larger segments of the market and cater to more niche needs.

Organovo Holdings, Inc. (ONVO), a clinical-stage biotech firm focused on advancing innovative treatments for inflammatory bowel ...

Although Li Auto doesn’t break down the key drivers of its growth, it’s quite likely that the Li L6, the most affordable ...

TMTPOST -- Chinese electric vehicle (EV) makers led by BYD Co. Ltd. finished the year 2024 with new monthly records, ...

Organovo Holdings, Inc. (Nasdaq:ONVO), a clinical stage biotechnology company focused on developing novel treatment approaches in inflammatory bowel disease (IBD) including ulcerative colitis, today ...

NIO's vehicle lineup and expansion efforts bode well for the long term, but persistent losses, financial strain, and rising ...

NIO-SW (09866.HK) (NIO.US) and its second brand, Onvo, jointly announced the launch of a limited-time last resort policy to ...

Organovo Holdings, Inc. (Nasdaq:ONVO), a clinical stage biotechnology company focused on developing novel treatment approaches in inflammatory bowel disease ...

NIO Inc.'s December delivery results have come as a surprise for many. The rigorous ramp of ONVO deliveries in the final weeks of 2024, alongside restored core brand sales at the 20,000+ monthly ...

With an enterprise value of $1.5 billion, Intuitive Machines still looks reasonably valued at 4 times next year's sales. So ...

NIO completed 61,855 deliveries for Q3 FY2024, up 7% QoQ. Check out why I believe NIO stock remains a solid speculative "Buy" ...

Trust a Chinese automaker to consistently push the boundaries of innovation. This time, it's the Shanghai-based electric car ...